VANI 8-K 2026-11-12

Vivani Medical, Inc. (VANI) 8-K dated 2026-11-12 — accession 0001753926-26-002108.

Vivani Medical, Inc. (VANI) is a biotechnology company listed on NASDAQ.

VANI to acquire platform ($15.5M)

This 8-K covers: Results of operations (Item 2.02), Reg FD disclosure (Item 7.01), Other events (Item 8.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported VANI revenue for 2025-12-31 was $0. Net income was -$26.6M. VANI currently screens at market cap $99.2M.

Not investment advice. The VANI SEC hub lists recent forms. The stock page is the research view.